Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
暂无分享,去创建一个
A. Gordon | Z. Sheng | A. Lauring | Lihong Liu | S. Iketani | Ian A. Mellis | D. Ho | Zhiteng Li | Yicheng Guo | Riccardo Valdez | Jian Yu | Michael Liu | Qian Wang | Zizhang Sheng
[1] F. Alt,et al. An Antibody from Single Human VH-rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion , 2022, Science Immunology.
[2] G. Pantaleo,et al. Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys , 2022, Nature Microbiology.
[3] R. Bloomquist,et al. PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2 , 2022, mSphere.
[4] D. Stuart,et al. Potent cross-reactive antibodies following Omicron breakthrough in vaccinees , 2022, Cell.
[5] J. Chan,et al. An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses , 2022, Science Translational Medicine.
[6] C. Rice,et al. Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins , 2022, Immunity.
[7] Chaim A. Schramm,et al. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants , 2021, Science.
[8] D. Stuart,et al. Antibody evasion by the P.1 strain of SARS-CoV-2 , 2021, Cell.
[9] M. Beltramello,et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms , 2020, Science.
[10] Lisa E. Gralinski,et al. Potently neutralizing and protective human antibodies against SARS-CoV-2 , 2020, Nature.
[11] M. Beltramello,et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody , 2020, Nature.
[12] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[13] A. Lapedes,et al. Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.